Tsai-Der Chuang

Title: Tsai-Der Chuang: Innovator in Biomedical Research

Introduction

Tsai-Der Chuang is a notable inventor based in Inglewood, California. He has made significant contributions to the field of biomedical research, particularly in the treatment of fibrotic disorders. With a total of two patents to his name, Chuang's work is focused on innovative methods and compositions that address critical health issues.

Latest Patents

Chuang's latest patents include "Compositions and methods for treating fibroids." This patent relates to compositions and methods aimed at treating fibroids in patients. It involves administering an effective amount of an agent that inhibits the expression or activity of TDO2 or IDO1. Another significant patent is "Methods of modulating miRNA levels and compositions for use in the same." This patent provides methods for modulating miRNA levels, such as miR-29c and/or miR-200c, in a cell. The methods include contacting the cell with an anti-fibrotic miRNA modulating active agent, such as a tranilast active agent. These methods and compositions are applicable in treating fibrotic disorders, including uterine leiomyoma.

Career Highlights

Chuang has worked at prominent institutions, including The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work at these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Chuang has collaborated with various professionals in his field, including Omid Khorram. These collaborations have enhanced his research efforts and contributed to the development of innovative solutions in biomedical science.

Conclusion

Tsai-Der Chuang is a distinguished inventor whose work in biomedical research has led to important advancements in the treatment of fibrotic disorders. His patents reflect a commitment to improving patient care through innovative methods and compositions.